Back to search

Article

Systematic Review and Meta-analysis of Eculizumab, Inebilizumab, Tocilizumab, and Satralizumab for Neuromyelitis Optica

2021-07-23

Abstract excerpt

Neuromyelitis optica is rare, autoimmune-mediated inflammation and demyelination of the central nervous system with a prevalence of 1-2 persons per 100,000 populations. We aim to generate a head-to-head comparison of these drugs with appropriate evidence to guide future trials and treatment guidelines in a patient with recurrent attacks of NMO. We searched the databases like PubMed, MEDLINE, Cochrane Central Regis...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0f2c7a3e-ce00-5378-bf9e-6d6d7108954c
DOI
10.1101/2021.07.22.21261005
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Systematic Review and Meta-analysis of Eculizumab, Inebilizumab, Tocilizumab, and Satralizumab for Neuromyelitis OpticaDOI 10.1101/2021.07.22.21261005
Unmet Needs in the Care of Patients with Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease: Insights from GermanySemantic proximity
Neuromyelitis optica is an HLA associated disease different from Multiple Sclerosis: a systematic review with meta-analysis.Semantic proximity
Differences in clinical features, disease outcomes and imaging features of demyelinating syndrome after MOG antibody therapySemantic proximity
Efficacy and safety of mycophenolate mofetil for steroid reduction in neuromyelitis optica spectrum disorder: a prospective cohort studySemantic proximity
Comparisons of clinical phenotype, radiological and laboratory features, and therapy of neuromyelitis optica spectrum disorder by regions: update and challenges.Semantic proximity
[Clinical features and modern diagnostic criteria of the disease associated with myelin oligodendrocyte glycoprotein antibody disease].Semantic proximity
The efficacy and safety of monoclonal antibody treatments against COVID-19: A systematic review and meta-analysis of randomized clinical trialsSemantic proximity
Clinical analysis of MOG antibody-associated disease overlapped with anti-NMDA receptor encephalitis: a long-term retrospective studySemantic proximity
Safety of SARS-CoV-2 vaccine in patients with autoimmune neurological conditions: a systematic review and meta-analysisSemantic proximity
The prevalence and clinical phenotype of dual seropositive neuromyelitis optica spectrum disorders at a national reference center in South Asia.Semantic proximity
Clinical and neuroimaging phenotypes of autoimmune glial fibrillary acidic protein astrocytopathy: A systematic review and meta-analysis.Semantic proximity
From Fragmented Evidence to a Unified GCC Demyelinating Disease Registry: A Strategic Framework for MS, NMOSD, MOGAD, Optic Neuritis, LETM, and Pediatric Acquired DemyelinationSemantic proximity
Select a neighboring publication to make it the new centre.